Multinational drug companies: issues in drug discovery and development
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York
Raven Pr.
1989
|
| Schlagworte: | |
| Beschreibung: | 2. Aufl. u.d.T.: Spilker, Bert: Multinational pharmaceutical companies |
| Beschreibung: | XXVI, 606 S. |
| ISBN: | 088167463X |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV002427211 | ||
| 003 | DE-604 | ||
| 005 | 20151220 | ||
| 007 | t | ||
| 008 | 900123s1989 |||| 00||| engod | ||
| 020 | |a 088167463X |9 0-88167-463-X | ||
| 035 | |a (OCoLC)18135500 | ||
| 035 | |a (DE-599)BVBBV002427211 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 | ||
| 050 | 0 | |a HD9665.5 | |
| 082 | 0 | |a 338.8/8716151 |2 20 | |
| 100 | 1 | |a Spilker, Bert |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Multinational drug companies |b issues in drug discovery and development |c Bert Spilker |
| 264 | 1 | |a New York |b Raven Pr. |c 1989 | |
| 300 | |a XXVI, 606 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a 2. Aufl. u.d.T.: Spilker, Bert: Multinational pharmaceutical companies | ||
| 650 | 4 | |a Entreprises multinationales | |
| 650 | 4 | |a Industrie pharmaceutique | |
| 650 | 4 | |a Industrie pharmaceutique - Innovations | |
| 650 | 4 | |a Médicaments - Recherche - Gestion | |
| 650 | 4 | |a Recherche | |
| 650 | 4 | |a Multinationales Unternehmen | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 4 | |a Drug Industry | |
| 650 | 4 | |a Drugs |x Research |x Management | |
| 650 | 4 | |a International business enterprises | |
| 650 | 4 | |a Pharmaceutical industry | |
| 650 | 4 | |a Pharmaceutical industry |x Technological innovations | |
| 650 | 4 | |a Research | |
| 650 | 4 | |a Technology, Pharmaceutical | |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Multinationales Unternehmen |0 (DE-588)4075092-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Multinationales Unternehmen |0 (DE-588)4075092-9 |D s |
| 689 | 0 | 2 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-001575463 | ||
Datensatz im Suchindex
| _version_ | 1804116851053035520 |
|---|---|
| any_adam_object | |
| author | Spilker, Bert |
| author_facet | Spilker, Bert |
| author_role | aut |
| author_sort | Spilker, Bert |
| author_variant | b s bs |
| building | Verbundindex |
| bvnumber | BV002427211 |
| callnumber-first | H - Social Science |
| callnumber-label | HD9665 |
| callnumber-raw | HD9665.5 |
| callnumber-search | HD9665.5 |
| callnumber-sort | HD 49665.5 |
| callnumber-subject | HD - Industries, Land Use, Labor |
| ctrlnum | (OCoLC)18135500 (DE-599)BVBBV002427211 |
| dewey-full | 338.8/8716151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.8/8716151 |
| dewey-search | 338.8/8716151 |
| dewey-sort | 3338.8 78716151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01917nam a2200541 c 4500</leader><controlfield tag="001">BV002427211</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20151220 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">900123s1989 |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">088167463X</subfield><subfield code="9">0-88167-463-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)18135500</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV002427211</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HD9665.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.8/8716151</subfield><subfield code="2">20</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Spilker, Bert</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multinational drug companies</subfield><subfield code="b">issues in drug discovery and development</subfield><subfield code="c">Bert Spilker</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Pr.</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVI, 606 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">2. Aufl. u.d.T.: Spilker, Bert: Multinational pharmaceutical companies</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entreprises multinationales</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Industrie pharmaceutique - Innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Recherche - Gestion</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recherche</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Multinationales Unternehmen</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Research</subfield><subfield code="x">Management</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">International business enterprises</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Technological innovations</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology, Pharmaceutical</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Multinationales Unternehmen</subfield><subfield code="0">(DE-588)4075092-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Multinationales Unternehmen</subfield><subfield code="0">(DE-588)4075092-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-001575463</subfield></datafield></record></collection> |
| id | DE-604.BV002427211 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:45:04Z |
| institution | BVB |
| isbn | 088167463X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-001575463 |
| oclc_num | 18135500 |
| open_access_boolean | |
| owner | DE-12 DE-188 |
| owner_facet | DE-12 DE-188 |
| physical | XXVI, 606 S. |
| publishDate | 1989 |
| publishDateSearch | 1989 |
| publishDateSort | 1989 |
| publisher | Raven Pr. |
| record_format | marc |
| spelling | Spilker, Bert Verfasser aut Multinational drug companies issues in drug discovery and development Bert Spilker New York Raven Pr. 1989 XXVI, 606 S. txt rdacontent n rdamedia nc rdacarrier 2. Aufl. u.d.T.: Spilker, Bert: Multinational pharmaceutical companies Entreprises multinationales Industrie pharmaceutique Industrie pharmaceutique - Innovations Médicaments - Recherche - Gestion Recherche Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Technology, Pharmaceutical Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Multinationales Unternehmen (DE-588)4075092-9 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 s Multinationales Unternehmen (DE-588)4075092-9 s Arzneimittelforschung (DE-588)4003120-2 s DE-604 |
| spellingShingle | Spilker, Bert Multinational drug companies issues in drug discovery and development Entreprises multinationales Industrie pharmaceutique Industrie pharmaceutique - Innovations Médicaments - Recherche - Gestion Recherche Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Technology, Pharmaceutical Pharmazeutische Industrie (DE-588)4045696-1 gnd Multinationales Unternehmen (DE-588)4075092-9 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4075092-9 (DE-588)4003120-2 |
| title | Multinational drug companies issues in drug discovery and development |
| title_auth | Multinational drug companies issues in drug discovery and development |
| title_exact_search | Multinational drug companies issues in drug discovery and development |
| title_full | Multinational drug companies issues in drug discovery and development Bert Spilker |
| title_fullStr | Multinational drug companies issues in drug discovery and development Bert Spilker |
| title_full_unstemmed | Multinational drug companies issues in drug discovery and development Bert Spilker |
| title_short | Multinational drug companies |
| title_sort | multinational drug companies issues in drug discovery and development |
| title_sub | issues in drug discovery and development |
| topic | Entreprises multinationales Industrie pharmaceutique Industrie pharmaceutique - Innovations Médicaments - Recherche - Gestion Recherche Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Technology, Pharmaceutical Pharmazeutische Industrie (DE-588)4045696-1 gnd Multinationales Unternehmen (DE-588)4075092-9 gnd Arzneimittelforschung (DE-588)4003120-2 gnd |
| topic_facet | Entreprises multinationales Industrie pharmaceutique Industrie pharmaceutique - Innovations Médicaments - Recherche - Gestion Recherche Multinationales Unternehmen Drug Evaluation, Preclinical Drug Industry Drugs Research Management International business enterprises Pharmaceutical industry Pharmaceutical industry Technological innovations Research Technology, Pharmaceutical Pharmazeutische Industrie Arzneimittelforschung |
| work_keys_str_mv | AT spilkerbert multinationaldrugcompaniesissuesindrugdiscoveryanddevelopment |